Item 1(a).
|
Name of Issuer:
|
Syros Pharmaceuticals, Inc. (the Issuer)
Item 1(b).
|
Address of Issuers Principal Executive Offices:
|
35 CambridgePark Drive, Cambridge, Massachusetts 02140
Item 2(a).
|
Name of Person Filing:
|
Item 2(b).
|
Address of Principal Business Office or, if none, Residence:
|
(i) Invus Public Equities, L.P. (Invus Public Equities)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Bermuda limited partnership
(ii) Invus Public Equities Advisors, LLC (Invus PE Advisors)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
(iii) Artal International S.C.A. (Artal International)
Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg
Citizenship: Luxembourg limited partnership
(iv) Artal International Management S.A. (Artal International Management)
Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg
Citizenship: Luxembourg société anonyme
(v) Artal Group S.A. (Artal Group)
Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg
Citizenship: Luxembourg société anonyme
(vi) Westend S.A. (Westend)
Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg
Citizenship: Luxembourg société anonyme
(vii) Stichting Administratiekantoor Westend (the Stichting)
Claude Debussylaan, 46, 1082 MD Amsterdam, The Netherlands
Citizenship: Netherlands foundation
(viii) Mr. Amaury Wittouck
Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg
Citizenship: Belgium
The foregoing persons are
hereinafter sometimes collectively referred to as the Reporting Persons.
Item 2(d).
|
Title of Class of Securities:
|
Common Stock, $0.001 par value per share (the Shares)
87184Q107
10